Lyxor Newcits IRL PLC - Lyxor/Sandler US Equity Fund EB USDFür den Zugriff auf unsere Ratings hier anmelden |
Wie hat sich dieser Fonds entwickelt? | 31.12.2017 |
Wachstum von 1000 (CHF) | Charts Erweitert |
![]() | Fonds | - | - | - | - | 4,6 |
![]() | +/-Kat | - | - | - | - | - |
![]() | +/-Idx | - | - | - | - | - |
Kategorie: Aktien Long/Short USA | ||||||
Kategorie Benchmark: Morningstar US TME NR USD |
Übersicht | ||
NAV 19.12.2017 | USD 108,42 | |
Änderung z. Vortag | 0,24% | |
Morningstar Kategorie™ | Aktien Long/Short USA | |
Valoren | 34702685 | |
ISIN | IE00BD8GKY45 | |
Fondsvolumen (Mio) 13.06.2024 | USD 542,03 | |
Anteilsklassenvol (Mio) 19.12.2017 | USD 0,11 | |
Ausgabeaufschlag (max.) | 5,00% | |
Laufende Kosten 12.06.2018 | 1,17% |
Anlageziel: Lyxor Newcits IRL PLC - Lyxor/Sandler US Equity Fund EB USD |
The investment objective of the Sub-Fund is to be exposed to the Strategy during the life of the Sub-Fund. The Strategy is based on two components, being (i) a proprietary discretionary trading strategy which has been developed by the Sub-Investment Manager (the “Trading Strategy”) and (ii) an allocation of any excess cash to liquid assets pursuant to a process defined and implemented solely by the Manager (the “Cash Portfolio”). |
Returns | ||||||||||
|
Management | ||
Fondsmanager Startdatum | ||
- - | ||
Anteilserstausgabe 15.11.2016 |
Werbung |
Kategorie Benchmark | |
Fondsbenchmark | Morningstar Benchmark |
S&P 500 TR EUR | Morningstar US TME NR USD |
Target Market | ||||||||||||||||||||
|
Was steckt in diesem Fonds? Lyxor Newcits IRL PLC - Lyxor/Sandler US Equity Fund EB USD | - |
|
|
Top 5 Positionen | Sektor | % |
Keine Daten verfügbar | ||
![]() | ||
![]() ![]() ![]() | ||
Lyxor Newcits IRL PLC - Lyxor/Sandler US Equity Fund EB USD | ||
*
All performances shown for this USD denominated fund in this website are expressed in Swiss Franc. If you want to see the USD based performance, please visit our UK website. |